Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 11/07/2025 pm IST			5-day change	1st Jan Change
438.95 ^DKK	-3.64%		-2.74%	-29.68%

10:02pm	European stocks down with bank and healthcare drag, US-EU tariffs in focus	RE
08:00pm	FDA May Fast Track Drug Reviews for Lower US Prices	MT

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,07,50,00,000	0	0	70.25 %
Stock B	1	3,39,00,00,000	3,13,65,64,503 ( 92.52 %)	2,40,00,000 ( 0.708 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	17,75,60,500	5.238 %	12 281 M kr
NOVO NORDISK A/S 0.7654 %	2,59,47,151	0.7654 %	1 795 M kr
State Street Global Advisors Ltd. 0.2048 %	69,42,248	0.2048 %	480 M kr
Sjunde AP-fonden 0.1328 %	45,02,464	0.1328 %	311 M kr
Amundi Asset Management SASU (Investment Management) 0.1252 %	42,45,139	0.1252 %	294 M kr
Eleva Capital SAS 0.1142 %	38,71,844	0.1142 %	268 M kr
ODIN Forvaltning AS 0.1129 %	38,27,519	0.1129 %	265 M kr
Capfi Delen Asset Management NV 0.1088 %	36,88,011	0.1088 %	255 M kr
Nordea Investment Management AB 0.1059 %	35,89,752	0.1059 %	248 M kr
State of Georgia (Invt Mgmt) 0.0957 %	32,44,454	0.0957 %	224 M kr
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.0115 %	3,91,310	0.0115 %	3 M kr
Western Asset Management Company DTVM Ltda. 0.009813 %	3,32,682	0.009813 %	3 M kr
Morgan Stanley Administradora de Carteiras SA 0.000003 %	100	0.000003 %	861 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,07,48,72,000	100 %	74 344 M kr
ANIMA Sgr SpA 0.0177 %	1,90,246	0.0177 %	13 M kr
Russell Investments Ltd. 0.002027 %	21,783	0.002027 %	2 M kr

Name	Equities	%	Valuation
Jennison Associates LLC 0.5552 %	1,88,22,002	0.5552 %	1 299 M kr
Merrill Lynch International 0.4363 %	1,47,92,624	0.4363 %	1 021 M kr
Loomis, Sayles & Co. LP 0.3654 %	1,23,88,242	0.3654 %	855 M kr
Eaton Vance Management 0.3634 %	1,23,19,787	0.3634 %	850 M kr
Fisher Asset Management LLC 0.3502 %	1,18,71,236	0.3502 %	819 M kr
Fayez Sarofim & Co. 0.3307 %	1,12,12,499	0.3307 %	774 M kr
RBC Private Counsel (USA), Inc. 0.2931 %	99,37,800	0.2931 %	686 M kr
Fidelity Management & Research Co. LLC 0.2841 %	96,32,932	0.2841 %	665 M kr
Folketrygdfondet 0.2809 %	95,21,912	0.2809 %	657 M kr
Capital Research & Management Co. (International Investors) 0.2806 %	95,11,545	0.2806 %	656 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	49.29%
Other	0.79%
Novo Nordisk A/S	0.77%
State Street Corp.	0.18%
Markel Group, Inc.	0.06%
Harel Insurance Investments & Financial Services Ltd.	0.02%
Menora Mivtachim Holdings Ltd.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
Migdal Insurance & Financial Holdings Ltd.	0.01%
SEI Investments Co.	0.01%
Unknown	48.85%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.99%
United States	8.17%
United Kingdom	1.3%
Norway	0.66%
Canada	0.46%
France	0.4%
Sweden	0.32%
Germany	0.3%
Italy	0.21%
Ireland	0.18%
Finland	0.18%
Australia	0.14%
Luxembourg	0.12%
Belgium	0.12%
Spain	0.11%
Switzerland	0.11%
Netherlands	0.1%
Taiwan	0.06%
Israel	0.04%
Japan	0.02%
Singapore	0.02%
Brazil	0.02%
Hong Kong	0.02%
Austria	0.02%
South Africa	0.02%
Portugal	0.01%
Liechtenstein	0.01%
Mexico	0.01%
Slovenia	0.01%
Iceland	0.01%
Individuals	-.--%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Employees

77,406

Sector

Pharmaceuticals

Calendar

06/08 - Q2 2025 Earnings Release

More about the company